These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24025384)

  • 21. The point of view of a high prevalence country: Malawi.
    Nyangulu DS
    Bull Int Union Tuberc Lung Dis; 1991 Dec; 66(4):173-4. PubMed ID: 1687509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tuberculosis diagnosed in a rural setting in Angola. Accuracy of follow-up sputum smears to predict outcome.
    López T; Moreno M; Salvador F; Zacarías A; Carvalho Rd; Tomás E; Estevao G; Eugenio AN; Burgos J; Sulleiro E; Molina I; Falcó V
    Pathog Glob Health; 2013 Jan; 107(1):5-10. PubMed ID: 23432857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for mortality in TB patients: a 10-year electronic record review in a South African province.
    Heunis JC; Kigozi NG; Chikobvu P; Botha S; van Rensburg HD
    BMC Public Health; 2017 Jan; 17(1):38. PubMed ID: 28061839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting results of mycobacterial culture on sputum smear reversion after anti-tuberculous treatment: a case control study.
    Shu CC; Wang JT; Lee CH; Wang JY; Lee LN; Yu CJ
    BMC Infect Dis; 2010 Mar; 10():48. PubMed ID: 20205743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Feasibility of a streamlined tuberculosis diagnosis and treatment initiation strategy.
    Shete PB; Nalugwa T; Farr K; Ojok C; Nantale M; Howlett P; Haguma P; Ochom E; Mugabe F; Joloba M; Chaisson LH; Dowdy DW; Moore D; Davis JL; Katamba A; Cattamanchi A
    Int J Tuberc Lung Dis; 2017 Jul; 21(7):746-752. PubMed ID: 28633698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of repeat sputum examination in RNTCP.
    Malik S; Dhingra VK; Hanif M; Vashist RP
    Indian J Tuberc; 2009 Jan; 56(1):17-21. PubMed ID: 19402268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tuberculosis programme changes and treatment outcomes in patients with smear-positive pulmonary tuberculosis in Blantyre, Malawi.
    Harries AD; Nyong'Onya Mbewe L; Salaniponi FM; Nyangulu DS; Veen J; Ringdal T; Nunn P
    Lancet; 1996 Mar; 347(9004):807-9. PubMed ID: 8622340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment outcomes and factors affecting treatment outcomes of new patients with tuberculosis in Busan, South Korea: a retrospective study of a citywide registry, 2014-2015.
    Mok J; An D; Kim S; Lee M; Kim C; Son H
    BMC Infect Dis; 2018 Dec; 18(1):655. PubMed ID: 30545315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low sputum smear positive tuberculosis among pulmonary tuberculosis suspects in a tertiary hospital in Mwanza, Tanzania.
    Seni J; Kidenya BR; Obassy E; Mirambo M; Burushi V; Mazigo HD; Kapesa A; Majigo M; Mshana SE
    Tanzan J Health Res; 2012 Apr; 14(2):115-20. PubMed ID: 26591732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gender disparity amongst TB suspects and new TB patients according to data recorded at the South African Institute of Medical Research laboratory for the Western Cape Region of South Africa.
    Austin JF; Dick JM; Zwarenstein M
    Int J Tuberc Lung Dis; 2004 Apr; 8(4):435-9. PubMed ID: 15141735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sputum conversion at the end of intensive phase of Category-1 regimen in the treatment of pulmonary tuberculosis patients with diabetes mellitus or HIV infection: An analysis of risk factors.
    Banu Rekha VV; Balasubramanian R; Swaminathan S; Ramachandran R; Rahman F; Sundaram V; Thyagarajan K; Selvakumar N; Adhilakshmi AR; Iliayas S; Narayanan PR
    Indian J Med Res; 2007 Nov; 126(5):452-8. PubMed ID: 18160750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sputum completion and conversion rates after intensive phase of tuberculosis treatment: an assessment of the Rwandan control program.
    Kayigamba FR; Bakker MI; Mugisha V; Gasana M; Schim van der Loeff MF
    BMC Res Notes; 2012 Jul; 5():357. PubMed ID: 22800438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of genotype MTBDRplus VER 2.0 line probe assay for the detection of MDR-TB in smear positive and negative sputum samples.
    Meaza A; Kebede A; Yaregal Z; Dagne Z; Moga S; Yenew B; Diriba G; Molalign H; Tadesse M; Adisse D; Getahun M; Desta K
    BMC Infect Dis; 2017 Apr; 17(1):280. PubMed ID: 28415989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Point-of-care Xpert® MTB/RIF for smear-negative tuberculosis suspects at a primary care clinic in South Africa.
    Van Rie A; Page-Shipp L; Hanrahan CF; Schnippel K; Dansey H; Bassett J; Clouse K; Scott L; Stevens W; Sanne I
    Int J Tuberc Lung Dis; 2013 Mar; 17(3):368-72. PubMed ID: 23407225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chest radiograph findings and time to culture conversion in patients with multidrug-resistant tuberculosis and HIV in Tugela Ferry, South Africa.
    Brust JC; Berman AR; Zalta B; Haramati LB; Ning Y; Heo M; van der Merwe TL; Bamber S; Moll AP; Friedland GH; Shah NS; Gandhi NR
    PLoS One; 2013; 8(9):e73975. PubMed ID: 24040132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors associated with month 2 smear non-conversion among Category 1 tuberculosis patients in Karachi, Pakistan.
    D'Souza KA; Zaidi SMA; Jaswal M; Butt S; Khowaja S; Habib SS; Malik AA
    J Infect Public Health; 2018; 11(2):283-285. PubMed ID: 28662884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficiency of a third serial sputum smear examination in the diagnosis of tuberculosis in Moldova and Uganda.
    Katamba A; Laticevschi D; Rieder HL
    Int J Tuberc Lung Dis; 2007 Jun; 11(6):659-64. PubMed ID: 17519098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of drug-resistant tuberculosis treatment outcome in Limpopo province, South Africa.
    Seloma NM; Makgatho ME; Maimela E
    Afr J Prim Health Care Fam Med; 2023 Jul; 15(1):e1-e7. PubMed ID: 37526555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tuberculosis treatment outcome and predictors in northern Ethiopian prisons: a five-year retrospective analysis.
    Adane K; Spigt M; Dinant GJ
    BMC Pulm Med; 2018 Feb; 18(1):37. PubMed ID: 29463234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment Outcome of Tuberculosis Patients under Directly Observed Treatment Short Course and Factors Affecting Outcome in Southern Ethiopia: A Five-Year Retrospective Study.
    Gebrezgabiher G; Romha G; Ejeta E; Asebe G; Zemene E; Ameni G
    PLoS One; 2016; 11(2):e0150560. PubMed ID: 26918458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.